Autobio(SH:603658) Sou Hu Cai Jing·2025-08-13 11:06Group 1 - The core viewpoint of the articles highlights the financial performance and market activity of Antu Biology (安图生物), indicating a decline in revenue and net profit in the latest quarterly report [1] - As of August 13, 2025, Antu Biology's stock closed at 42.16 yuan, down 0.28%, with a trading volume of 42,600 lots and a transaction amount of 179 million yuan [1] - The company experienced a net outflow of main funds amounting to 10.72 million yuan, representing 5.98% of the transaction amount, with significant outflows from large orders [1] Group 2 - For the first quarter of 2025, Antu Biology reported total operating revenue of 996 million yuan, a year-on-year decrease of 8.56%, and a net profit attributable to shareholders of 270 million yuan, down 16.76% year-on-year [1] - The company has a current ratio of 2.625, a quick ratio of 2.149, and a debt-to-asset ratio of 25.05%, indicating a strong liquidity position [1] - Antu Biology has made investments in 19 companies and participated in 1,183 bidding projects, showcasing its active engagement in the market [2]